DURECT Corp (DRRX):企業の財務・戦略的SWOT分析

◆英語タイトル:DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1589
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

DURECT Corp (DRRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DURECT Corp (Durect) is a biopharmaceutical company that focuses on research and development of new chemical entities for the treatment of acute organ injury and chronic liver diseases based on its endogenous epigenetic regulator program. The company’s major product pipeline comprises DUR-928, indicated for the treatment of alcoholic hepatitis and nonalcoholic steatohepatitis (NASH); Posimir, indicated to treat post-operative pain; and Oradur, indicated for chronic pain and attention deficit hyperactivity disorders. It also manufactures and sells osmotic pumps for laboratory research; and offers standard and custom biodegradable polymers and excipients for customers in pharmaceutical and medical device industry. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in Cupertino, California, the US.

DURECT Corp Key Recent Developments

Mar 03,2020 DURECT announces fourth quarter and full year 2019 financial results and update of programs
Nov 04,2019 DURECT corporation announces third quarter 2019 financial results and update of programs
Aug 01,2019 DURECT announces second quarter 2019 financial results and update of programs
May 07,2019 DURECT announces first quarter 2019 financial results and update of programs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
DURECT Corp – Key Facts
DURECT Corp – Key Employees
DURECT Corp – Key Employee Biographies
DURECT Corp – Major Products and Services
DURECT Corp – History
DURECT Corp – Company Statement
DURECT Corp – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
DURECT Corp – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
Geographical Segment: United States
Performance
DURECT Corp – Corporate Strategy
DURECT Corp – SWOT Analysis
SWOT Analysis – Overview
DURECT Corp – Strengths
DURECT Corp – Weaknesses
DURECT Corp – Opportunities
DURECT Corp – Threats
DURECT Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
DURECT Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
DURECT Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
DURECT Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 03, 2020: DURECT announces fourth quarter and full year 2019 financial results and update of programs
Nov 04, 2019: DURECT corporation announces third quarter 2019 financial results and update of programs
Aug 01, 2019: DURECT announces second quarter 2019 financial results and update of programs
May 07, 2019: DURECT announces first quarter 2019 financial results and update of programs
Apr 25, 2019: DURECT appoints two new board members
Mar 07, 2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
DURECT Corp, Key Facts
DURECT Corp, Key Employees
DURECT Corp, Key Employee Biographies
DURECT Corp, Major Products and Services
DURECT Corp, History
DURECT Corp, Key Competitors
DURECT Corp, Ratios based on current share price
DURECT Corp, Annual Ratios
DURECT Corp, Annual Ratios (Cont...1)
DURECT Corp, Interim Ratios
DURECT Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
DURECT Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
DURECT Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
DURECT Corp, Performance Chart (2015 - 2019)
DURECT Corp, Ratio Charts
DURECT Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
DURECT Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[DURECT Corp (DRRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KfW Group:企業の戦略的SWOT分析
    KfW Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Foxconn Technology Co Ltd:企業のM&A・事業提携・投資動向
    Foxconn Technology Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Foxconn Technology Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ExlService Holdings, Inc.:企業の戦略・SWOT・財務情報
    ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Metacrine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary portfolio of non-bile acid FXR agonists through its chemistry and …
  • Academy Sports + Outdoors:企業の戦略・SWOT・財務情報
    Academy Sports + Outdoors - Strategy, SWOT and Corporate Finance Report Summary Academy Sports + Outdoors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dermalogica, Inc.:企業の戦略・SWOT・財務情報
    Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Muehlbauer Holding AG & Co. KGaA (MUB):企業の財務・戦略的SWOT分析
    Muehlbauer Holding AG & Co. KGaA (MUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SR Technics Holding:企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Facebook, Inc.:企業のM&A・事業提携・投資動向
    Facebook, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Facebook, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …
  • National Grid Plc (NG):電力:M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • Alcoa Inc:戦略・SWOT・企業財務分析
    Alcoa Inc - Strategy, SWOT and Corporate Finance Report Summary Alcoa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Synchronoss Technologies, Inc. (SNCR):企業の財務・戦略的SWOT分析
    Synchronoss Technologies, Inc. (SNCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Cummins Inc.:企業の戦略・SWOT・財務分析
    Cummins Inc. - Strategy, SWOT and Corporate Finance Report Summary Cummins Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆